We then wondered if there was any relationship between tumor burden, evaluated as number of circulating neoplastic cells at T1, expressed as percentage of clonal CD4+TCRVβ+ calculated within total CD4+ T cells, and the number of persistent mutated genes found in each patient. This evidence concerns the gene CD4 and neoplasm.